Market Tracker

12/22 5:21am ET

Albany Molecular Research Inc (NASDAQ:AMRI)

14.89
Data as of Dec 19
 -0.15 / -1.00%
Today’s Change
9.71
Today|||52-Week Range
23.95
+47.72%
Year-to-Date

Today’s Trading

Previous close15.04
Today’s open15.10
Day’s range-- - --
Volume743,907
Average volume (3 months)521,368
Market cap$485.5M
Dividend yield--
Data as of 12/19/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2.38%
Earnings growth (next 5 years)+13.70%
Revenue growth (last year)+8.77%
P/E ratio148.9
Price/Sales1.26
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
FLXNFlexion Therapeutics...+0.24+1.14%
LXRXLexicon Pharmaceutic...-0.04-4.42%
ARWRArrowhead Research C...+0.28+4.58%
EXELExelixis Inc-0.02-1.48%
Data as of 12/19/2014

Financials

Next reporting dateFebruary 9, 2015
EPS forecast (this quarter)$0.33
Annual revenue (last year)$246.6M
Annual profit (last year)$12.7M
Net profit margin5.14%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
SVP
Michael M. Nolan
Corporate headquarters
Albany, New York

Forecasts